Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia

ClinicalTrials.gov ID: NCT03771664

Public ClinicalTrials.gov record NCT03771664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult participants with comorbid major depressive disorder (MDD) and insomnia.

Study identification

NCT ID
NCT03771664
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
87 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 4, 2019 (Actual)
Primary completion
Dec 20, 2019 (Actual)
Completion
Jan 17, 2020 (Actual)
Last update posted
Nov 29, 2023

2019 – 2020

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
Sage Investigational Site Little Rock Arkansas 72211 —
Sage Investigational Site Rogers Arkansas 72758 —
Sage Investigational Site Garden Grove California 92845 —
Sage Investigational Site Oceanside California 92056 —
Sage Investigational Site San Diego California 92103 —
Sage Investigational Site Temecula California 92591 —
Sage Investigational Site Fort Myers Florida 33912 —
Sage Investigational Site Hollywood Florida 33024 —
Sage Investigational Site Miami Lakes Florida 33016 —
Sage Investigational Site North Miami Florida 33161 —
Sage Investigational Site Atlanta Georgia 30331 —
Sage Investigational Site Atlanta Georgia 30342 —
Sage Investigational Site Decatur Georgia 30030 —
Sage Investigational Site Chicago Illinois 60634 —
Sage Investigational Site Lake Charles Louisiana 70629 —
Sage Investigational Site Flowood Mississippi 39232 —
Sage Investigational Site St Louis Missouri 63141 —
Sage Investigational Site Las Vegas Nevada 89102 —
Sage Investigational Site Berlin New Jersey 08009 —
Sage Investigational Site Albuquerque New Mexico 87109 —
Sage Investigational Site Brooklyn New York 11235 —
Sage Investigational Site New York New York 10019 —
Sage Investigational Site Cincinnati Ohio 45212 —
Sage Investigational Site Dayton Ohio 45417 —
Sage Investigational Site Oklahoma City Oklahoma 73103 —
Sage Investigational Site Salem Oregon 97301 —
Sage Investigational Site Charleston South Carolina 29407 —
Sage Investigational Site Austin Texas 78754 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03771664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2023 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03771664 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →